ALBANY, N.Y., March 4, 2021 /PRNewswire/ -- Voice prosthesis devices are gaining clinical acceptance for speech rehabilitation in patients, especially in patients with laryngeal and hypopharyngeal ...
Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results